Experienced in Disseminated Tuberculosis

Yinzhong R. Shen

2901 Caolang Road, 
Shanghai, CN 
Experienced in Disseminated Tuberculosis
2901 Caolang Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Yinzhong Shen practices in Shanghai, China. Shen is rated as an Experienced expert by MediFind in the treatment of Disseminated Tuberculosis. Their top areas of expertise are HIV/AIDS, Cryptococcosis, Severe Acute Respiratory Syndrome (SARS), and Avian Influenza.

Their clinical research consists of co-authoring 162 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Disseminated Tuberculosis.

Locations

2901 Caolang Road, Shanghai, 201508, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants With Mild to Moderate COVID-19.
A Multicenter, Double-blind, Randomized, Placebo-Controlled, Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of JT001 (VV116) for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Participants With Mild to Moderate COVID-19.
Enrollment Status: Terminated
Publish Date: September 22, 2023
Intervention Type: Drug
Study Drug: JT001
Study Phase: Phase 2/Phase 3
A Multi-center, Double-blinded, Randomized, Phase III Study to Evaluate the Efficacy and Safety of JT001 (VV116) Compared With Favipiravir in Participants With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
A Multi-center, Double-blinded, Randomized, Phase III Study to Evaluate the Efficacy and Safety of JT001 (VV116) Compared With Favipiravir in Participants With Moderate to Severe Coronavirus Disease 2019 (COVID-19)
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

162 Total Publications

Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2.
Plasma proteomic profiling of hospitalized patients co-infected with HIV and SARS-CoV-2.
Journal: Frontiers in immunology
Published: March 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Shen's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile